GT Biopharma (GTBP) Institutional Ownership → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free GTBP Stock Alerts $3.26 +0.21 (+6.89%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for GT Biopharma (NASDAQ:GTBP)CurrentInstitutional OwnershipPercentage8.15%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$5.58MNumber ofInstitutional Sellers(last 12 months)0 Get GTBP Insider Trade Alerts Want to know when executives and insiders are buying or selling GT Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GTBP Institutional Buying and Selling by Quarter Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. GT Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/2/2023 Bank of Montreal Can596,240$262K0.0%N/A1.596% 1/23/2023 Baskin Financial Services Inc.151,354$134K0.0%N/A0.466% 11/7/2022Virtu Financial LLC24,864$44K0.0%N/A0.076% 5/5/2022 Russell Investments Group Ltd.11,007$31K0.0%N/A0.033% 5/2/2022 Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078% 4/20/2022 Sigma Planning Corp21,400$62K0.0%N/A0.067% Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/14/2022 Gordian Capital Singapore Pte Ltd35,000$107K0.1%N/A0.114% 2/9/2022 Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098% 2/4/2022 Crumly & Associates Inc.32,163$85K0.0%N/A0.105% 2/3/2022 Brighton Jones LLC11,288$34K0.0%N/A0.037% 1/31/2022Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036% 11/16/2021 Two Sigma Advisers LP51,100$344K0.0%+243.0%0.242% 11/16/2021 Two Sigma Investments LP162,823$1.10M0.0%N/A0.771% 11/15/2021 Marshall Wace LLP16,577$112K0.0%-35.7%0.078% 11/15/2021 Franklin Resources Inc.28,500$192K0.0%N/A0.135% 11/12/2021 Renaissance Technologies LLC84,700$571K0.0%N/A0.401% 11/12/2021 Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008% 11/10/2021 Goldman Sachs Group Inc.52,426$353K0.0%N/A0.248% 11/9/2021 BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468% 11/8/2021 State Board of Administration of Florida Retirement System18,224$123K0.0%N/A0.086% 11/8/2021 Russell Investments Group Ltd.9,642$64K0.0%N/A0.046% 11/5/2021 Welch Group LLC10,000$67K0.0%N/A0.047% 11/4/2021 Deutsche Bank AG11,400$77K0.0%-25.7%0.054% 11/2/2021 New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039% 8/25/2021 Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/17/2021 Metropolitan Life Insurance Co NY8,782$136K0.0%N/A0.042% 8/17/2021 MetLife Investment Management LLC11,471$178K0.0%N/A0.054% 8/17/2021 Citadel Advisors LLC510,058$7.91M0.0%N/A2.414% 8/16/2021California State Teachers Retirement System32,878$510K0.0%N/A0.156% 8/16/2021 Charles Schwab Investment Management Inc.57,993$899K0.0%N/A0.274% 8/16/2021 State Street Corp374,704$5.81M0.0%N/A1.773% 8/16/2021 Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389% 8/16/2021 Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/13/2021 Northern Trust Corp225,457$3.50M0.0%+555.6%1.067% 8/13/2021 Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641% 8/13/2021 Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649% 8/12/2021 Legal & General Group Plc2,524$39K0.0%N/A0.012% 8/12/2021 JPMorgan Chase & Co.9,155$142K0.0%N/A0.043% 8/12/2021 The Manufacturers Life Insurance Company13,758$213K0.0%N/A0.065% 8/11/2021 Bank of New York Mellon Corp58,711$910K0.0%N/A0.278% 348 million Americans lives to END as we know it? (Ad)348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...To see my free research, simply click here now.8/11/2021 BlackRock Inc.1,413,391$21.91M0.0%N/A6.690% 8/11/2021 Deutsche Bank AG15,349$237K0.0%N/A0.073% 8/10/2021 Citigroup Inc.6,134$95K0.0%N/A0.029% 8/6/2021 Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009% 8/5/2021 Rhumbline Advisers18,634$289K0.0%N/A0.088% 8/2/2021 New York State Common Retirement Fund20,400$316K0.0%N/A0.097% 8/2/2021 Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014% 7/31/2021 Davy Global Fund Management Ltd35,113$544K0.1%+33.4%0.166% 7/15/2021 Compagnie Lombard Odier SCmA15,000$233K0.0%N/A0.071% 7/6/2021 Silverleafe Capital Partners LLC104,000$1.61M0.6%N/A0.492% 5/19/2021Virtu Financial LLC22,741$156K0.0%N/A0.080% 5/19/2021 Squarepoint Ops LLC16,543$113K0.0%N/A0.058% 5/18/2021 Millennium Management LLC27,895$191K0.0%N/A0.098% 5/17/2021 Royal Bank of Canada24,542$167K0.0%N/A0.086% 5/12/2021 Northern Trust Corp34,387$235K0.0%N/A0.121% 5/12/2021 Geode Capital Management LLC130,388$891K0.0%N/A0.459% 5/12/2021 UBS Group AG3,918$27K0.0%N/A0.014% 5/11/2021 Davy Global Fund Management Ltd26,321$180K0.0%N/A0.093% (Data available from 1/1/2016 forward) GTBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GTBP shares? During the previous two years, the following institutional investors and hedge funds held shares of GT Biopharma shares: Bank of Montreal Can ($262K), and Baskin Financial Services Inc. ($134K), Virtu Financial LLC ($44K).Learn more on GTBP's institutional investors. What percentage of GT Biopharma stock is owned by institutional investors? 8.15% of GT Biopharma stock is owned by institutional investors. Learn more on GTBP's institutional investor holdings. Which institutional investors have been buying GT Biopharma stock? The following institutional investors have purchased GT Biopharma stock in the last 24 months: Bank of Montreal Can ($596.24K), Baskin Financial Services Inc. ($151.35K), and Virtu Financial LLC ($24.86K). How much institutional buying is happening at GT Biopharma? Institutional investors have bought a total of 772,458 shares in the last 24 months. This purchase volume represents approximately $10.92M in transactions. Related Companies: Petros Pharmaceuticals Major Shareholders Clever Leaves Major Shareholders ZyVersa Therapeutics Major Shareholders Soligenix Major Shareholders Kazia Therapeutics Major Shareholders Longeveron Major Shareholders Exicure Major Shareholders NexImmune Major Shareholders Ensysce Biosciences Major Shareholders Seelos Therapeutics Major Shareholders This page (NASDAQ:GTBP) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.